Biodexa Pharmaceuticals

NASDAQ: BDRX · Real-Time Price · USD
7.08
0.04 (0.57%)
At close: Aug 15, 2025, 3:59 PM
7.00
-1.13%
After-hours: Aug 15, 2025, 07:51 PM EDT

Biodexa Pharmaceuticals Balance Sheet Statement

Financials in GBP. Fiscal year is January - December.
Fiscal Year Q4 2024 Q2 2024 Q4 2023 Q2 2023 Q4 2022 Q2 2022 Q4 2021 Q2 2021
Period Ending Dec 31, 2024 Jun 30, 2024 Dec 31, 2023 Jun 30, 2023 Dec 31, 2022 Jun 30, 2022 Dec 31, 2021 Jun 30, 2021
Cash & Equivalents
1.67M 5.05M 5.97M 5.23M 2.84M 6.42M 10.06M 4.2M
Short-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Assets
n/a n/a n/a -698K -837K -993K -1.15M -1.25M
Receivables
715K 1.92M n/a 2.04M 329K 1.24M 33K 1.4M
Inventory
n/a n/a -704K -1.13M n/a n/a n/a n/a
Other Current Assets
n/a 547K n/a n/a n/a 1.02M n/a 1.42M
Total Current Assets
8.81M 7.52M 7.03M 7.26M 4.69M 8.69M 11.76M 7.03M
Property-Plant & Equipment
324K 436K 571K 693K 831K 993K 1.15M 1.25M
Goodwill & Intangibles
5.65M 6.01M 2.94M 5K 6K n/a n/a n/a
Total Long-Term Assets
5.97M 6.44M 3.51M 698K 837K 993K 1.15M 1.25M
Total Assets
14.78M 13.97M 10.54M 7.96M 5.53M 9.68M 12.91M 8.28M
Account Payables
707K 1.69M 314K 1.75M 339K 1.28M 485K 2.04M
Deferred Revenue
1.47M n/a 926K n/a 197K n/a n/a n/a
Short-Term Debt
430K n/a n/a n/a n/a n/a n/a n/a
Other Current Liabilities
491K 1.62M 4.23M 364K 583K 198K 664K 1.67M
Total Current Liabilities
5.03M 3.48M 5.57M 2.28M 1.9M 1.65M 1.84M 3.84M
Long-Term Debt
n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities
1.31M 1.55M n/a -294 n/a n/a n/a n/a
Total Long-Term Liabilities
1.42M 1.76M 295K 379.71K 463K 546K 620K 682K
Total Liabilities
6.46M 5.24M 5.86M 2.66M 2.36M 2.19M 2.46M 4.52M
Total Debt
727K 382K 464K 544K 624K 546K 620K 682K
Common Stock
6.69M 3.63M 1.19M 277.97K 1.11M 98K 98K 63K
Retained Earnings
-150.42M -147.88M -144.77M -138.97M -135.34M -130.76M -127.8M -125.55M
Comprehensive Income
53M 61.74M 53M 53M 53M 54.72M 54.72M 54.72M
Shareholders Equity
8.32M 8.73M 4.68M 5.3M 3.16M 7.49M 10.45M 3.75M
Total Investments
n/a n/a n/a n/a n/a n/a n/a n/a